Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Riding High on Potential Cannabis, Nicotine Uses of Patented Technology
Lexaria Bioscience is helping to revolutionize efforts to provide common drug substances in an ingestible method that avoids unhealthy practices such as inhaled smoking or vaping Lexaria’s DehydraTECH platform works to deliver the chemical compounds to the blood stream at speeds comparable to inhalation methods, providing the means for discrete use and avoiding frustrating waits for users with dependencies The company recently obtained a patent in Australia that recognizes DehydraTECH not only as a food and beverage platform, but also as a potential means of pharmaceutical use for combatting select illnesses As Canada prepares to introduce legalization of cannabis food…